VERTEX PHARMACEUTICALS INC / MA Net Change in Cash 2008-2026 | VRTX
What is net change in cash?
Net change in cash represents the total increase or decrease in cash and cash equivalents during the reporting period.
What is VERTEX PHARMACEUTICALS INC / MA's current net change in cash?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual net change in cash for 2025 was $515.6M, a 108.89% increase from 2024. VERTEX PHARMACEUTICALS INC / MA net change in cash for the quarter ending March 31, 2026 was $417.1M.
What was VERTEX PHARMACEUTICALS INC / MA's net change in cash in 2024?
VERTEX PHARMACEUTICALS INC / MA annual net change in cash for 2024 was $-5.80B, a 4051.83% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's net change in cash in 2023?
VERTEX PHARMACEUTICALS INC / MA annual net change in cash for 2023 was $-139.7M, a 103.76% decline from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year net change in cash CAGR?
VERTEX PHARMACEUTICALS INC / MA net change in cash grew at a compound annual growth rate (CAGR) of 29.05% from FY2020 to FY2025, going from $2.87B to $515.6M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $515.6M | +108.9% | 10-K |
| FY2024 | $-5.80B | -4051.8% | 10-K |
| FY2023 | $-139.7M | -103.8% | 10-K |
| FY2022 | $3.71B | +357.6% | 10-K |
| FY2021 | $811.2M | -71.7% | 10-K |
| FY2020 | $2.87B | +520.3% | 10-K |
| FY2019 | $462.4M | -53.3% | 10-K |
| FY2018 | $990.7M | +127.3% | 10-K |
| FY2017 | $435.8M | -7.1% | 10-K |
| FY2016 | $469.2M | +424.2% | 10-K |
| FY2015 | $89.5M | +144.0% | 10-K |
| FY2010 | $-203.5M | -453.6% | 10-K |
| FY2009 | $57.5M | +72.0% | 10-K |
| FY2008 | $33.5M | - | 10-K |